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10. Guentert, T. W., Rakhit, A., Upton, R. A., and Riegelman, S., An CLIN. CHEM. 28/7, 1509-1513 (1982) integrated approach to measurements of quinidine and metabolites in biological fluids. J. Chromatogr. (Riomed. AppI.) 183, 514-518 (1980 (5, (8) (9) (10) or by radioimmunoassay (RIA) with tritium or iodine-125 labeled tracers (11) (12) (13) (14) . Each method of analysis has its advantages and disadvantages. However, the sensitivity, speed of analysis, and small sample volume required for RIA make it a desirable method of analysis.
The purpose of this study was to design and validate an RIA for PCP in serum specimens. The use of an 125! tracer, low cross-reactivity antibody, and a solid-phase second-antibody separation method proved both sensitive and specific. We also report PCP disposition studies in two dogs, to illustrate the utility of the assay.
Materials and Methods

Reagents and Standards
Standards. The suspension was diluted fourfold with RIA buffer and a 100-.tL aliquot was used to precipitate antibody-bound radioactivity.
The second-antibody preparation was added in excess of the anti-PCP sera concentration to assure complete precipitation of the rabbit anti-phencyclidine immunoglobulins.
Procedures
RIA. The radioligand was added to the RIA buffer to give a concentration of 235 ng/L, and 0.2 mL was pipetted into 10 X 75 mm glass test tubes. Then 0.1 mL of standard, control, or unknown serum was added to appropriately labeled tubes, in duplicate.
Serum specimens with phencyclidine concentration >100 jig/L were diluted with blank serum so that concentrations would be within the range of the standard curve-i.e., 1-100 zg/L. The anti-PCP sera was diluted 15 000-fold (25-35% antibody binding in the absence of PCP) with RIA buffer, and 0.1 mL was added to all tubes except the tubes for nonspecific binding and total radioactivity. To the latter tubes, 0.1 mL of buffer was added. After vortex-mixing, the tubes were incubated at 30-35 #{176}C for 1-2 h, then 0.1 mL of the solid-phase second antibody was added to all tubes except the tubes used to determine total counts. The tubes were further incubated at room temperature for 15 mm with the second-antibody preparation and then centifuged at 1000
X g for 5 mm to precipitate antibody-bound radioactivity. The supernatant fluid was aspirated and the pellet washed with 0.8 mL of buffer. After centrifugation, the supernate was aspirated.
The radioactivity in the pellet was counted in a gamma counter with 74.5% efficiency. The results were usually computer-calculated by the four-parameter logistic model (16, 17) . However, we summarized the results for the average standard curve by using the logit-log transformation of the average counts from duplicate tubes (18) . Gas chromatography.
We analyzed for PCP in serum specimens by a modification of the gas-chromatographic
tube, and the samples were shaken vigorously for 30 mm, centrifuged, and the organic layer was removed and transferred to a second tube containing 2 mL of 0.1 mol/L H2S04. The samples were shaken for 30 mm and centrifuged, the organic layer was aspirated, and the remaining aqueous layer was alkalinized with 1 mL of the Na2CO3 solution. Three milliliters of fresh extraction solvent was added, and the tubes were shaken vigorously for 30 mm and centrifuged. Two milliliters of the organic layer was transferred to a siliconized 10 X 75 mm culture tube and evaporated under a gentle steam of nitrogen at 40 #{176}C. The residue was dissolved in 15 iL of methanol, and 1 iL was injected into the gas chromatograph with use of a splitless mode. A Hewlett-Packard gas chromatograph (Model 5840A) equipped with a nitrogen-phosphorus detector and a Hewlett-Packard 25M methyl silicone capillary column were used for the analysis. Analysis for PCP was optimal under the following conditions: injection port temperature, 200#{176}C; detector temperature, 300 #{176}C; oven temperature, programmed at 130 #{176}C for 0.5 mm, increased at a rate of 30 #{176}C/min, then held at 210 #{176}C for 6 mm; carrier gas (helium) flow rate, 2.0 mL/min; air flow rate, 100 mL/min; hydrogen flow rate, 3.5 mL/min; make-up gas (helium) flow rate, 40 mL/min. Detector bead current was adjusted to give a 10-cm pen deflection at a 28 attenuation.
Retention times for PCP and 1,1-phenylcyclohexylmorpholine were 6.25 and 6.95 mm, respectively.
Serum unknowns.
Phencyclidmne hydrochloride (1 mg/kg as the free base) in physiological saline was administered to two normal mongrel dogs (18.8 and 22.3 kg) by intravenous bolus injection. Blood specimens were collected at specified times for 36 h thereafter. Serum specimens were refrigerated at 4-8 #{176}C until analyzed. All analyses were completed within five days after specimens were collected.2
Comparison
of the RIA with the gas-chromatographic method. Thirty PCP-positive specimens from the PCP dosing study were analyzed by the RIA and the gas-chromatographic method in a blind fashion. We plotted and compared the results, using a linear regression model and nonparametric statistical tests. -
Results and Discussion
a.
. of reproducibility. Therefore, 0.2 mL of serum can be used if a more-sensitive detection limit is required. The equation for the RIA dose-response curve, calculated by the logit-log transformation for 15 consecutive assays, was y = -2.16x + 2.84 (r2 = 0.978). The concentration of PCP needed to displace 50% of the radioligand from binding to the antibody was 20.7 sg/L. A primary concern in any RIA is the specificity of the antibody. Heveran et al. (11) found no cross reactivity with this anti-PCP sera with 20 commonly prescribed drugs. However, they found a different cross reactivity of the antibody with the PCP metabolite 1-(l-phenylcyclohexyl)-4-hydroxypiperidine supplied from two different sources (11, 12), so we tested the cross reactivity of this PCP metabolite and of another major PCP metabolite, 4-phenyl-4-piperidinocyclohexanol. The cross reactivities of each compound were compared at the concentration needed to displace 50% of the radioligand from binding to the antibody. This concentration, divided by the 50% displacement concentration of PCP and multiplied by 100, gave the relative percent cross reactivity. The respective cross reactivity for the above metabolites was 1.4 and 2.9%. Heveran and Ward (12) found 1.7 and 3.6% cross reactivity, respectively. However, these metabolites are found primarily as conjugates in blood (19) . Because of the high antibody specificity for PCP, we would expect conjugated metabolites to be even less cross reactive. We were unable to
7, 7/
a. (12) found that the only significant cross-reacting compounds were PCP analogs. This RIA for PCP in serum will give accurate results only if these structural analogs are not present. If this RIA is used for clinical or forensic purposes, exact identification must be performed by a different method of analysis, such as gas chromatographymass spectrometry. However, only PCP or some of its analogs should cross react with the antibody.
The within-day and day-to-day reproducibility and analytical recovery for the RIA in human serum and dog serum were good (Table 1 ). The reproducibility of the gas chromatographic method was also good (Table 1) .
The solid-phase goat anti-rabbit antibody we used in this RIA produced <0.5% non-specific binding; therefore, assay noise and misclassification errors were kept to a minimum (21, 22 (Figure 1 ). Because PCP can produce deleterious effects in humans, we used the dog as an animal model to study the disposition kinetics of PCP. We determined the serum concentrations of PCP over time in two mongrel dogs that had received an intravenous bolus dose of 1 mg of PCP per kilogram body weight (Figure 2) . The concentration-time data were best described by a bi-exponential function with terminal elimination halflives of 2.3 and 4.1 h.
In conclusion, we found the sensitivity and reproducibility of our RIA to be slightly better than that of our gas-chromatographic method, while requiring only one-fifth the sample volume and much less analysis time.
